Latest news with #IntegratedResearchLimited
Yahoo
05-05-2025
- Business
- Yahoo
Should You Think About Buying Integrated Research Limited (ASX:IRI) Now?
While Integrated Research Limited (ASX:IRI) might not have the largest market cap around , it led the ASX gainers with a relatively large price hike in the past couple of weeks. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy? Let's examine Integrated Research's valuation and outlook in more detail to determine if there's still a bargain opportunity. We've discovered 3 warning signs about Integrated Research. View them for free. Good news, investors! Integrated Research is still a bargain right now according to our price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. we find that Integrated Research's ratio of 3.98x is below its peer average of 67.89x, which indicates the stock is trading at a lower price compared to the Software industry. What's more interesting is that, Integrated Research's share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market. Check out our latest analysis for Integrated Research Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with an extremely negative double-digit change in profit expected over the next couple of years, near-term growth is certainly not a driver of a buy decision. It seems like high uncertainty is on the cards for Integrated Research, at least in the near future. Are you a shareholder? Although IRI is currently trading below the industry PE ratio, the adverse prospect of negative growth brings about some degree of risk. Consider whether you want to increase your portfolio exposure to IRI, or whether diversifying into another stock may be a better move for your total risk and return. Are you a potential investor? If you've been keeping tabs on IRI for some time, but hesitant on making the leap, we recommend you dig deeper into the stock. Given its current price multiple, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. For instance, we've identified 3 warning signs for Integrated Research (1 is a bit unpleasant) you should be familiar with. If you are no longer interested in Integrated Research, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
01-04-2025
- Business
- Yahoo
3 Promising ASX Penny Stocks With Market Caps Under A$2B
Despite recent market turbulence, including a significant drop on Monday, Australian shares are poised for a rebound, with ASX 200 futures indicating a potential rise. For investors exploring beyond the well-known names, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities. While the term might seem outdated, these stocks can present growth potential at lower price points when backed by strong financials and sound fundamentals. Name Share Price Market Cap Financial Health Rating CTI Logistics (ASX:CLX) A$1.585 A$123.65M ★★★★☆☆ MotorCycle Holdings (ASX:MTO) A$2.06 A$152.04M ★★★★★★ Accent Group (ASX:AX1) A$1.785 A$1.01B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.53 A$72.17M ★★★★★★ IVE Group (ASX:IGL) A$2.35 A$363.06M ★★★★★☆ GTN (ASX:GTN) A$0.60 A$117.83M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.26 A$154.69M ★★★★★★ Regal Partners (ASX:RPL) A$2.25 A$754.64M ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.82 A$480.97M ★★★★★★ NRW Holdings (ASX:NWH) A$2.80 A$1.28B ★★★★★☆ Click here to see the full list of 969 stocks from our ASX Penny Stocks screener. Let's uncover some gems from our specialized screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: BKI Investment Company Limited is a publicly owned investment manager with a market cap of A$1.35 billion. Operations: The company generates revenue of A$68.44 million from the securities industry segment. Market Cap: A$1.35B BKI Investment Company Limited, with a market cap of A$1.35 billion, is debt-free and maintains stable weekly volatility at 2%. Despite high-quality earnings, recent negative earnings growth (-9.7%) contrasts with the Capital Markets industry average of 23.6%. The company's net profit margin decreased to 89.3% from last year's 94.8%, and its return on equity remains low at 4.4%. BKI's short-term assets (A$112.4M) exceed short-term liabilities (A$1.9M), but do not cover long-term liabilities (A$116.9M). The seasoned board boasts an average tenure of 21.5 years, supporting strategic stability amidst these challenges. Click here and access our complete financial health analysis report to understand the dynamics of BKI Investment. Assess BKI Investment's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Integrated Research Limited specializes in designing, developing, implementing, and selling systems and applications management software for business-critical computing, unified communication, and payment networks with a market cap of A$85.13 million. Operations: The company generates revenue from its Software & Programming segment, amounting to A$71.29 million. Market Cap: A$85.13M Integrated Research Limited, with a market cap of A$85.13 million, has turned profitable, reporting high-quality earnings and a strong return on equity of 22.3%. The company is debt-free and trades at a favorable price-to-earnings ratio of 4.1x compared to the Australian market average of 17.4x. However, recent earnings results show declining revenue (A$28.84 million) and net income (A$4.57 million) for the half year ended December 31, 2024, compared to the previous year's figures. Despite these challenges, its short-term assets significantly cover both short-term and long-term liabilities, indicating financial stability amidst volatility concerns. Click here to discover the nuances of Integrated Research with our detailed analytical financial health report. Evaluate Integrated Research's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Omni Bridgeway Limited provides dispute and litigation finance services across multiple regions including Australia, the United States, Canada, Latin America, Asia, New Zealand, Europe, the Middle East, and Africa with a market capitalization of A$418.22 million. Operations: The company generates revenue of A$132.66 million from funding and providing services related to legal dispute resolution. Market Cap: A$418.22M Omni Bridgeway Limited, with a market cap of A$418.22 million, remains unprofitable despite generating A$132.66 million in revenue from its legal dispute resolution services. The company has seen increased losses over the past five years and a negative return on equity of 1.85%. However, it maintains a satisfactory net debt to equity ratio of 6.1% and has sufficient cash runway for over three years due to positive free cash flow. Recent executive changes include David Breeney's appointment as Global Chief Financial Officer, bringing extensive experience from his tenure at Challenger Limited. Take a closer look at Omni Bridgeway's potential here in our financial health report. Learn about Omni Bridgeway's future growth trajectory here. Unlock our comprehensive list of 969 ASX Penny Stocks by clicking here. Ready For A Different Approach? AI is about to change healthcare. These 24 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:BKI ASX:IRI and ASX:OBL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
04-02-2025
- Business
- Yahoo
Discover 3 Promising ASX Penny Stocks Under A$200M Market Cap
As the Australian market navigates through the complexities of global trade tensions and a fluctuating commodities landscape, investors are keeping a close eye on opportunities that might arise amidst these shifts. Penny stocks, often representing smaller or newer companies, continue to capture interest due to their potential for unexpected growth. Despite being an older term in investment circles, these stocks can still offer intriguing prospects when backed by solid financial health and resilience. Name Share Price Market Cap Financial Health Rating Embark Early Education (ASX:EVO) A$0.79 A$141.28M ★★★★☆☆ LaserBond (ASX:LBL) A$0.575 A$66.82M ★★★★★★ Austin Engineering (ASX:ANG) A$0.50 A$310.07M ★★★★★☆ SHAPE Australia (ASX:SHA) A$3.00 A$247.9M ★★★★★★ GTN (ASX:GTN) A$0.535 A$105.06M ★★★★★★ Helloworld Travel (ASX:HLO) A$1.94 A$322.38M ★★★★★★ MaxiPARTS (ASX:MXI) A$1.90 A$106.21M ★★★★★★ IVE Group (ASX:IGL) A$2.20 A$334.56M ★★★★☆☆ Centrepoint Alliance (ASX:CAF) A$0.31 A$61.65M ★★★★★☆ Nickel Industries (ASX:NIC) A$0.745 A$3.2B ★★★★★☆ Click here to see the full list of 1,032 stocks from our ASX Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, unified communication, and payment networks with a market cap of A$78.04 million. Operations: The company generates revenue of A$83.29 million from its software and programming segment. Market Cap: A$78.04M Integrated Research Limited, with a market cap of A$78.04 million, recently achieved profitability, a significant milestone for a company in its segment. The firm generates revenue of A$83.29 million from its software and programming operations and maintains a debt-free balance sheet, which enhances financial stability. Its short-term assets comfortably cover both short- and long-term liabilities, reducing financial risk. However, the management team and board are relatively inexperienced with average tenures under two years. Despite trading at an attractive price-to-earnings ratio of 2.9x compared to the broader Australian market's 19.3x, earnings are forecast to decline over the next three years. Jump into the full analysis health report here for a deeper understanding of Integrated Research. Review our growth performance report to gain insights into Integrated Research's future. Simply Wall St Financial Health Rating: ★★★★★★ Overview: OzAurum Resources Limited is involved in the development and exploration of gold, lithium, and rare earth elements in Western Australia, with a market cap of A$10.32 million. Operations: The company generates revenue primarily from its mineral exploration activities, amounting to A$0.15 million. Market Cap: A$10.32M OzAurum Resources Limited, with a market cap of A$10.32 million, is pre-revenue and focuses on gold, lithium, and rare earth exploration in Western Australia. The company remains debt-free and has short-term assets of A$1.2 million that exceed both its short- and long-term liabilities. Despite high volatility in share price over the past three months, OzAurum's recent capital raise bolsters its cash runway to six months. The addition of Jessica Fertig as an independent director brings valuable expertise in investor relations to the board following Andy Tudor's resignation, potentially enhancing strategic direction amidst ongoing exploration efforts. Click to explore a detailed breakdown of our findings in OzAurum Resources' financial health report. Review our historical performance report to gain insights into OzAurum Resources' track record. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Saunders International Limited, with a market cap of A$132.74 million, offers design, construction, fabrication, shutdown, maintenance, and industrial automation services for steel storage tanks and concrete bridges in Australia and the Pacific Region. Operations: Saunders International generates revenue of A$216.08 million from its steel storage tanks, concrete bridges, and structural mechanical piping segments. Market Cap: A$132.74M Saunders International Limited, with a market cap of A$132.74 million, has demonstrated financial stability with short-term assets of A$66.9 million surpassing both short- and long-term liabilities. The company is debt-free, reducing financial risk, and its earnings have grown significantly over the past five years despite recent negative growth. Trading at 60.1% below estimated fair value suggests potential undervaluation, though insider selling in the last quarter raises caution. While Saunders maintains high-quality earnings and an experienced board, its dividend history is unstable and return on equity remains low at 18.3%, indicating room for improvement in profitability metrics. Unlock comprehensive insights into our analysis of Saunders International stock in this financial health report. Examine Saunders International's past performance report to understand how it has performed in prior years. Access the full spectrum of 1,032 ASX Penny Stocks by clicking on this link. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:IRI ASX:OZM and ASX:SND. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
